Finance

Lists
SILO:IDX
Siloam International Hospitals Tbk PT
1 900,00 IDR
0,00%
(0,00) 1D
13-окт., 15:15:32 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SILO...
Open
1 900 IDR
High
1 915 IDR
Low
1 890 IDR
Mkt. cap
24,71 трлн
Avg. vol.
1,47 млн
Volume
437,20 миң
P/E ratio
19,96
52-wk high
2 880 IDR
52-wk low
1 840 IDR
EPS
95 IDR
Shares outstanding
13,01 млд
No. of employees
15 миң
Open
1 900 IDR
High
1 915 IDR
Low
1 890 IDR
Mkt. cap
24,71 трлн
Avg. vol.
1,47 млн
Volume
437,20 миң
P/E ratio
19,96
52-wk high
2 880 IDR
52-wk low
1 840 IDR
EPS
95 IDR
Shares outstanding
13,01 млд
No. of employees
15 миң
News stories
From web sources and news partners
Profile
PT Siloam International Hospitals Tbk or Siloam Hospitals is a chain of healthcare facilities in Indonesia founded in 1996 by PT. Lippo Karawaci Tbk. It is a publicly listed company which is part of Lippo Group. Wikipedia
About Siloam International Hospitals Tbk PT
CEO-
Employees14,7 миң
Founded1996-ж., 27-авг.
HeadquartersТангеранг, Бантен, Индонезия
SectorHealth care provider
Last report
2026-ж., 30-июл.
Fiscal period
Q2 2026
- / -
Revenue / Est. (IDR)
3,49 трлн / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
3,32 трлн
3,42 трлн
3,28 трлн
3,49 трлн
Cost of goods sold
2,08 трлн
2,10 трлн
2,08 трлн
2,21 трлн
Cost of revenue
2,08 трлн
2,10 трлн
2,08 трлн
2,21 трлн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
722,64 млд
738,98 млд
738,36 млд
755,42 млд
Operating expense
769,58 млд
801,39 млд
776,68 млд
813,06 млд
Total operating expenses
2,85 трлн
2,91 трлн
2,86 трлн
3,02 трлн
Operating income
470,34 млд
516,10 млд
421,50 млд
464,75 млд
Other non operating income
-6,84 млд
-9,94 млд
-9,34 млд
-11,36 млд
EBT including unusual items
428,16 млд
475,15 млд
382,93 млд
422,51 млд
EBT excluding unusual items
428,16 млд
475,15 млд
382,93 млд
422,51 млд
Income tax expense
107,46 млд
108,10 млд
89,35 млд
106,62 млд
Effective tax rate
25,10%
22,75%
23,33%
25,24%
Other operating expenses
46,94 млд
62,41 млд
38,32 млд
57,64 млд
Net income
304,52 млд
351,32 млд
279,97 млд
300,71 млд
Net profit margin
9,17%
10,27%
8,54%
8,63%
Earnings per share
-
-
-
-
Interest and investment income
3,94 млд
5,88 млд
6,44 млд
8,53 млд
Interest expense
-30,42 млд
-27,88 млд
-26,99 млд
-31,43 млд
Net interest expenses
-26,49 млд
-22,00 млд
-20,55 млд
-22,89 млд
Depreciation and amortization charges
-
-
-
-
EBITDA
595,74 млд
643,43 млд
563,11 млд
612,54 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору